Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen

Antivir Ther. 2004 Aug;9(4):635-6.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / administration & dosage
  • Adenine / analogs & derivatives*
  • Adenine / blood
  • Adenine / therapeutic use*
  • Cohort Studies
  • Drug Therapy, Combination
  • France
  • Genotype
  • HIV Infections / blood
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Reverse Transcriptase
  • HIV-2 / genetics*
  • HIV-2 / isolation & purification
  • Humans
  • Mutation*
  • Organophosphonates / administration & dosage
  • Organophosphonates / blood
  • Organophosphonates / therapeutic use*
  • RNA-Directed DNA Polymerase / genetics*
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Tenofovir
  • Time Factors

Substances

  • Organophosphonates
  • Reverse Transcriptase Inhibitors
  • Tenofovir
  • reverse transcriptase, Human immunodeficiency virus 2
  • HIV Reverse Transcriptase
  • RNA-Directed DNA Polymerase
  • Adenine